AstraZeneca PLC Stock Forecast for 2023 - 2025 - 2030

Updated on 05/28/2024

Stock Rating
17
Price Target
£168.68
Consensus
Outperform
Upside
37.18%
Analysts
16
Stock Rating
17
Upside
37.18%
Analysts
16
Price Target
£168.68

AstraZeneca PLC Stock Forecast and Price Target

AstraZeneca PLC has an average price target of £168.68 recently offered by sixteen notable experts for 2024, which would represent a potential upside of approximately 37.18% from the last closing price in May, 2024 if reached. This potential increase is based on a high estimate of £220.19 and a low estimate of £131.28. If you're looking to buy AstraZeneca PLC stock, you may also want to check out its rivals.

£168.68

37.18% Upside

Outperform
Outperform

AstraZeneca PLC Fair Value Forecast for 2023 - 2025 - 2030

AstraZeneca PLC's Price has decreased In the last four years, from £69.51 to £0.00 – a 100.00% drop. In the next year, analysts predict that Fair Value will reach £140.05 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
£140.05
2025 Fair Value Forecast
£163.74
2026 Fair Value Forecast
£184.14
2027 Fair Value Forecast
£199.70
2028 Fair Value Forecast
£201.95
2029 Fair Value Forecast
£215.43
2030 Fair Value Forecast
£224.42
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LLY Stock Forecast Eli Lilly and Outperform 16
$807.43 Buy/Sell $636.99 8.68%
NOVO B Stock Forecast Novo Nordisk A/S Outperform 12
kr919.70 Buy/Sell kr696.07 4.65%
JNJ Stock Forecast Johnson & Johnson Outperform 9
$146.97 Buy/Sell $174.55 15.67%
MRK Stock Forecast Merck Outperform 2
$129.49 Buy/Sell $130.51 11.21%
ABBV Stock Forecast AbbVie Outperform 9
$157.06 Buy/Sell $178.42 16.20%

AstraZeneca PLC Revenue Forecast for 2023 - 2025 - 2030

AstraZeneca PLC's Revenue has grown in the last three years, jumping from £26.62B to £45.81B – an increase of 72.11%. In the next year, analysts predict that Revenue will reach £50.38B – an increase of 9.98%. For the next seven years, the forecast is for Revenue to grow by 41.93%.

2024 Rev Forecast
£50.38B
2025 Rev Forecast
£54.30B
2026 Rev Forecast
£57.57B
2027 Rev Forecast
£60.03B
2028 Rev Forecast
£61.51B
2029 Rev Forecast
£63.76B
2030 Rev Forecast
£65.02B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
NOVN Stock Forecast Novartis Hold 10
CHF92.03 Buy/Sell CHF105.00 16.94%
ABT Stock Forecast Abbott Laboratories Outperform 9
$103.95 Buy/Sell $118.92 20.25%
AMGN Stock Forecast Amgen Outperform 4
$305.84 Buy/Sell $303.65 5.38%

AstraZeneca PLC Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, AstraZeneca PLC's Dividend per Share has increased by 3.57%, going from £2.80 to £2.90. In the next year, analysts are expecting an increase in Dividend per Share, predicting it will reach £3.16 – an increase of 8.97%. The AstraZeneca PLC forecast is for Dividend per Share to reach £5.28 or grow by 82.07%.

2024 DPS Forecast
£3.16
2025 DPS Forecast
£3.29
2026 DPS Forecast
£3.48
2027 DPS Forecast
£3.70
2028 DPS Forecast
£4.26
2029 DPS Forecast
£5.03
2030 DPS Forecast
£5.28
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
MDT Stock Forecast Medtronic Outperform 11
$82.29 Buy/Sell $92.47 16.66%
GSK Stock Forecast GSK Outperform 12
£17.75 Buy/Sell £17.30 12.39%
CSL Stock Forecast CSL Outperform 12
$280.64 Buy/Sell $205.51 -26.79%

AstraZeneca PLC Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
£9.94B
2025 FCF Forecast
£12.75B
2026 FCF Forecast
£14.22B
2027 FCF Forecast
£15.93B
2028 FCF Forecast
£20.14B
2029 FCF Forecast
£21.48B
2030 FCF Forecast
£23.52B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BMY Stock Forecast Bristol-Myers Squibb Hold 2
$41.24 Buy/Sell $58.15 30.94%
GILD Stock Forecast Gilead Sciences Inc Outperform 11
$65.68 Buy/Sell $87.82 21.80%
MRK Stock Forecast Merck KGaA Outperform 18
167.40€ Buy/Sell 190.06€ 9.32%

AstraZeneca PLC EBITDA Forecast for 2023 - 2025 - 2030

AstraZeneca PLC's EBITDA has increased by 121.91% In the last three years, going from £6.76B to £15.01B. In the next year, analysts expect EBITDA to reach £18.11B – an increase of 20.62%. For the next seven years, the forecast is for EBITDA to grow by 49.72%.

2024 EBITDA Forecast
£18.11B
2025 EBITDA Forecast
£20.15B
2026 EBITDA Forecast
£22.10B
2027 EBITDA Forecast
£23.81B
2028 EBITDA Forecast
£21.56B
2029 EBITDA Forecast
£22.12B
2030 EBITDA Forecast
£22.47B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
4568 Stock Forecast Daiichi Sankyo Company Buy 4
¥5.63k Buy/Sell ¥5.24k 10.18%
BDX Stock Forecast Becton Dickinson and Co Outperform 9
$228.79 Buy/Sell $284.47 22.38%
MRNA Stock Forecast Moderna Outperform 16
$166.61 Buy/Sell $135.42 -24.37%

AstraZeneca PLC EBIT Forecast for 2023 - 2025 - 2030

In the last three years, AstraZeneca PLC's EBIT has grown, increasing from £4.15B to £10.43B – a growth of 151.54%. The next year looks promising for AstraZeneca PLC, with analysts predicting EBIT of £17.26B – an increase of 65.42%. Over the next seven years, experts anticipate that AstraZeneca PLC's EBIT will grow at a rate of 152.82%.

2024 EBIT Forecast
£17.26B
2025 EBIT Forecast
£19.48B
2026 EBIT Forecast
£21.05B
2027 EBIT Forecast
£22.76B
2028 EBIT Forecast
£23.83B
2029 EBIT Forecast
£25.36B
2030 EBIT Forecast
£26.38B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
MMM Stock Forecast 3M Hold 10
$99.67 Buy/Sell $109.39 3.84%
4519 Stock Forecast Chugai Pharmaceutical Outperform 6
¥4.81k Buy/Sell ¥4.92k 26.90%
BAS Stock Forecast BASF Outperform 12
48.76€ Buy/Sell 49.50€ 14.85%

AstraZeneca PLC EPS Price Prediction Forecast for 2023 - 2025 - 2030

AstraZeneca PLC's EPS has decreased In the last four years, from £4.02 to £0.00 – a 100.00% drop. In the next year, analysts predict that EPS will reach £8.10 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
£8.10
2025 EPS Forecast
£9.47
2026 EPS Forecast
£10.65
2027 EPS Forecast
£11.55
2028 EPS Forecast
£11.68
2029 EPS Forecast
£12.46
2030 EPS Forecast
£12.98
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LONN Stock Forecast Lonza Group Buy 16
CHF512.80 Buy/Sell CHF516.89 17.00%
CTVA Stock Forecast Corteva Outperform 12
$55.51 Buy/Sell $61.72 17.10%
BIIB Stock Forecast Biogen Outperform 10
$217.81 Buy/Sell $299.62 32.45%